This news is delayed by 15 minutes, sign up now to get live news & full features.
TBPH THERAVANCE BIOPHARMA INC
+ add to watchlist
$18.43
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.
Mkt Cap: $933.89M
52 Week High: $20.33
P/E: -8.84
52 Week Low: $7.90
Dividend: $0.00
Shares Outstanding: 50.67M